The fund owned 55,714 shares of the biopharmaceutical company’s stock after acquiring an additional 2,564 shares during the period. Hengehold Capital Management LLC now owns 131,224 shares of the biopharmaceutical company’s stock worth $3,181,000 after purchasing an additional 3,486 shares in the last quarter. Chatham Capital Group Inc. now owns 28,890 shares of the biopharmaceutical company’s stock valued at $700,000 after acquiring an additional 1,000 shares during the period. Kiley Juergens Wealth Management LLC now owns 16,543 shares of the biopharmaceutical company’s stock worth $401,000 after buying an additional 1,101 shares during the period. Get Pfizer alerts:Pfizer Stock Up 0.6%Shares of Pfizer stock opened at $23.75 on Friday.